NL
KZR

NWAM LLC’s Kezar Life Sciences KZR Stock Holding History

NWAM LLC’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,259
Closed -$209K – 538
2022
Q1 		$209K Hold
1,259
– – 0.02% 502
2021
Q4 		$211K Hold
1,259
– – 0.02% 479
2021
Q3 		$109K Hold
1,259
– – 0.01% 483
2021
Q2 		$68K Hold
1,259
– – 0.01% 466
2021
Q1 		$75K Hold
1,259
– – 0.01% 484
2020
Q4 		$66K Hold
1,259
– – 0.01% 449
2020
Q3 		$61K Buy
+1,259
New +$60.2K 0.01% 243

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

NWAM LLC's KZR Position: Q2 2022 in Review

NWAM LLC sold out of Kezar Life Sciences (KZR) in Q2 2022, closing a stake of 1,259 shares — an estimated $209K sold.

NWAM LLC first reported a position in KZR in Q3 2020 and held it in 7 quarters. The position peaked at $211K in Q4 2021. 127 funds tracked by Wall St. Rank hold KZR as of Q2 2022.

  • NWAM LLC reported no remaining Kezar Life Sciences position as of Q2 2022 after selling out during the quarter.
  • NWAM LLC sold 1,259 Kezar Life Sciences shares in Q2 2022, an estimated $209K.
  • NWAM LLC first reported a position in Kezar Life Sciences in Q3 2020 and held it in 7 quarters.
  • NWAM LLC's Kezar Life Sciences position peaked at $211K in Q4 2021.
  • 127 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2022.

Based on NWAM LLC's 13F filing for Q2 2022, filed 10 Aug 2022.